Full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonrandomized population of 259 patients

• Authors: SKŘIČKOVÁ Jana; KADLEC Bohdan; VENCLÍČEK O.; JANÁSKOVÁ T.; BARTOŠ J.; CHALUPA J.; KOLEK V.; GRYGÁRKOVÁ I.; ČOUPKOVÁ H.; REITERER P.
• Year of publication: 2012
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine

Attached files

• Skrickovlung_cancer_005.pdf

• Description: The purpose of this trial was to evaluate the activity and feasibility of CBDCA together with full oral vinorelbin (NVBO) in 1st line treatment NSCLC patients. This is a prospective nerandomizovanou study of 259 patients.This is a prospective nerandomizovanou study of 259 patients.